https://ly335979modulator.com/....standardizing-preope
To compare direct oral anticoagulants (DOACs) with low-molecular-weight heparin (LMWH) in the prevention of recurrent venous thromboembolism (VTE) and the associated risk of bleeding in patients with cancer who have had a prior venous thromboembolism event. In the US, at 67 oncology practices, a noninferiority, randomized, comparative effectiveness clinical trial, unblinded, was performed on 671 patients with cancer (comprising any
처럼
논평
공유하다
